Cite
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.
MLA
D’Alterio, Crescenzo, et al. “Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.” Cancers, vol. 14, no. 7, Apr. 2022, p. 1849. EBSCOhost, https://doi.org/10.3390/cancers14071849.
APA
D’Alterio, C., Spina, A., Arenare, L., Chiodini, P., Napolitano, M., Galdiero, F., Portella, L., Simeon, V., Signoriello, S., Raspagliesi, F., Lorusso, D., Pisano, C., Colombo, N., Zannoni, G. F., Losito, N. S., De Cecio, R., Scognamiglio, G., Califano, D., Russo, D., & Tuninetti, V. (2022). Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients. Cancers, 14(7), 1849. https://doi.org/10.3390/cancers14071849
Chicago
D’Alterio, Crescenzo, Anna Spina, Laura Arenare, Paolo Chiodini, Maria Napolitano, Francesca Galdiero, Luigi Portella, et al. 2022. “Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.” Cancers 14 (7): 1849. doi:10.3390/cancers14071849.